Advicenne: CDC holds less than 25% of votes
Following this threshold crossing, which resulted from an Advicenne capital increase, CDC stated that it indirectly held 2,664,505 shares representing 21.62% of the capital and 23.63% of the voting rights of this biopharmaceutical company.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction